Support for Your In Vitro Diagnostic Regulation (IVDR) Compliance Transition
In May 2017, EU officials announced regulations impacting organizations that manufacture in vitro diagnostic devices in both Europe and the United States. In order to sell their products in the European market, organizations must complete compliance with these new regulations by May 2022.
While the deadline of May 2022 for complying with the In Vitro Diagnostic Regulations (IVDR) might seem far away, when you consider the challenges ahead it’s important to start taking steps now to prepare.
- Access an infographic to guide you through the steps, the key dates to remember, and other insights on how to achieve IVDR compliance on schedule
- Learn how a large pharmaceutical organization was able to achieve compliance and deliver 50 new combination products to market
- Explore how Oxford’s IVDR staffing and consulting services are tailored to fit your organization’s needs